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LETTERS TO THE EDITOR
Skin Type, Melanoma, and Melanocortin 1 Receptor Variants
To the Editor:
We were interested to read the recent paper by Ichii-Jones et al
(1998) published in the Journal of Investigative Dermatology. The
authors searched for particular variants of the melanocortin 1
receptor (MC1R) using restriction fragment length polymorphism
analysis and performed a case control study with skin type and
melanoma. Essentially the authors failed to find any significant
relationship between the particular variants they examined and
phenotype. We would contend that there are strong associations
between particular variants of the MC1R and skin type and possibly
with melanoma. We suggest two reasons that may have contributed
to the apparent discrepancy between the authors’ results and those
previously published by ourselves and others (Valverde et al, 1995,
1996; Box et al, 1997; Smith et al, 1998).
There are over 20 known variants of the MC1R. In our original
Nature Genetics paper (Valverde et al, 1995) we detected some but
not all of these. As was appropriate for an initial survey, putative
associations required confirmation and Ichii-Jones et al’s paper is a
welcome contribution to this. Subsequent work by ourselves and
by others has shown that three particular variants, the Arg151Cys,
Arg160Trp, and Asp294His variants, are strongly associated with
red hair with a majority of individuals with red hair being either
compound heterozygotes or homozygotes for one of these three
alleles. To this extent red hair approximates to a Mendelian recessive
model (Smith et al, 1998). Importantly the relative risks for red
hair and possession of one of these alleles are actually quite high
(8–15-fold). We would therefore suggest that the results of Ichii-
Jones et al can be accounted for in two ways. First, previous study
by ourselves failed to find any association between the codon 92
variant or the codon 84 variant and skin type or hair color (Valverde
et al, 1996). This was confirmed in the study by Box et al (1997)
and more recently by Smith et al (1998). The failure of Ichii-Jones
et al to detect a statistically significant association between the
Asp294His variant and hair color or skin type is perhaps more
surprising. One possibility is that Ichii-Jones et al carried out much
of their phenotypic assessment in busy outpatients where (as they
state) insufficient time meant that not all clinical data were obtained
from all patients. Furthermore the authors report that many different
individuals carried out the skin typing and assessment of hair color.
We think use of standardized hair charts together with a more
rigorous assessment of skin type is preferable. We suspect that this
is the likely explanation for their failure to detect a relation between
the 294 variant and hair color or skin type. The recent publication
of evidence of functional impairment of the Arg151Cys variant
(Fra¨ndberg et al, 1998) together with our own unpublished observa-
tions on the Asp294His and Arg151Cys, strongly support a role
for these particular variants in the red hair/skin type I phenotype.
In their study, Ichii-Jones et al (1998) reported that allele
frequencies were not different in melanoma cases and controls for
any of the three MC1R variants investigated, but that after
correction for imbalances in age, gender, and skin type, the
association of the Asp84Glu allele with increased risk of melanoma
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approached significance (p 5 0.069, odds ratio 5 3.0, 95% CI 5
0.9–9.6); however, because of the large number of MC1R variants
that exist and because in our previous study on MC1R variants in
subjects with melanoma only the second and seventh transmem-
brane domains were sequenced (Valverde et al, 1996), the question
still remains open whether many of the numerous MC1R variants
predispose to melanoma, or whether certain variants confer higher
risk than others. Subsequently we have examined the entire coding
region of the MC1R gene by bidirectional automated sequencing
in 26 individuals, 20 of whom were included in our original study
and who did not contain the Asp84Glu variant. In addition, the
frequency of the Asp84Glu variant was investigated by restriction
fragment length polymorphism analysis in another 26 individuals
from a similar U.K. population, none of whom were included in
our original study. DNA was extracted from blood, paraffin-
embedded skin or paraffin-embedded melanoma from subjects with
cutaneous melanoma [in our original study variants that were
present in the melanoma were also always present in the germline,
and chromosome arm 16q where the MC1R gene is located does
not seem to be a target for loss of heterozygosity in cutaneous
melanoma (Healy et al, 1996)]. MC1R variants were identified in
16 of the 26 melanoma cases that were sequenced for the entire
coding region of the MC1R gene [with the Val60Leu variant
observed in 11 cases (Table I)]; however, the Asp84Glu variant
was identified in only two of the 32 patients who were not included
in our previous study, suggesting that the Asp84Glu variant is not
as frequent as previously suspected in melanoma patients, and that
this variant is unlikely to be a major risk factor for the development
of cutaneous melanoma. The overall frequency of MC1R variants
in the 26 melanoma patients in whom the gene was sequenced
does not differ significantly from that detected by our group, and
recently reported in the Journal of Investigative Dermatology (Smith
et al, 1998), in a fair skinned Caucasian population (16 of 26
melanoma cases versus 53 of 71 Irish individuals, Chi2 5 0.278,
p 5 0.597). It seems likely that the variation between the studies
is primarily due to population sampling because of the large number
of variants that exist in the MC1R gene, and we are reluctant at
this stage to attribute any special importance to the association of
the Val60Leu variant with melanoma for instance.
We would suggest that, at the current time, sequencing of the
entire MC1R gene is essential in investigations relating to many
variants with particular phenotypes. Study of selected restriction
fragment length polymorphisms may miss significant associations,
as we would contend with the Ichii-Jones study. MC1R variants
are associated with red hair and fair skin, phenotypic characteristics
Table I. MC1R variants detected by sequencing the entire
MC1R coding region in 26 individuals with cutaneous
melanoma
Variant Number of cases with variant
Val60Leu 11
Val92Met 3
Arg142His 2
Arg151Cys 3
Arg160Trp 1
Arg163Gln 1
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that render individuals susceptible to cutaneous melanoma, but
further work is required to dissect out whether MC1R variants in
melanoma act independently of the skin type phenotype.
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Reply
Healy et al raise some interesting points in their letter regarding the
importanceof polymorphism in themelanocortin1 receptor (MCIR)
and its association with skin type, hair color, and susceptibility to
melanoma. We have been studying putative associations between
polymorphic candidate genes and susceptibility to skin cancer. We
have identified allelic variants at several loci that are associated with
multiple basal cell carcinomas or a shorter time from first to second
presentation (Lear et al, 1996). In some cases, we identified inter-
actions between genotypes and skin type 1 that were associated with
a worst clinical outcome. Accordingly, the Valverde et al (1995) study
showing a particularly strong association between allelic variants at
the MC1R and red hair and skin type 1 was of considerable interest
as a candidate for cutaneous cancers. We initially looked at three of
the described alleles, Val92Met, Asp294His, and Asp84Glu, in
patients with melanoma. We selected these from the nine alleles
described because Val92Met and Asp294His appeared to be relative
common and Asp84Glu had been associated with susceptibility to
melanoma in a small case control study (Valverde et al, 1996). We
studied 306 melanoma cases and 190 controls and attempted to show
associations between alleles and skin type and hair color in both
groups. In the case group we attempted to also demonstrate differ-
ences in allele frequency with tumor type and site (Ichii-Jones et al,
1998).
We failed to confirm the strong association between allelic variants
and skin type reported by Valverde et al (1995). None the less, in the
control group we did identify a significant association between skin
type and a group comprising all the controls with any one or more
of the three alleles studied. Thus, although we did not find the strong
association previously reported for individual alleles, our data do
support the view that allelic variation at the MC1R is associated
with skin type. Importantly, this association was not evident in the
melanoma case group.
Healy et al also comment on the association between MC1R allelic
variants and hair color. They report that three variants – Arg151Cys,
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Arg160Trp, and Asp294His – are strongly associated with red hair.
The data presented in our study also indicate that Asp294His is
associated with red hair in both controls and melanoma cases. This
association only approached statistical significance (p 5 0.10) in our
study (Ichii-Jones et al, 1998). We believe this reflects the relatively
small number of red-haired subjects that we were able to recruit.
Further studies in a larger patient group have shown a statistically
significant association between this allele and red hair.
Overall therefore, we find the association between MC1R alleles
and skin type to be less strong than reported by Valverde et al (1995).
We agree that Asp294His (but not Val92Met or Asp84Glu) are associ-
ated with red hair. We note the suggestion of Healy et al that the
discrepancies between our data and theirs might result from our
inability to properly classify patients as skin type 1 or having red
hair. All classifications of skin type were carried out by experienced
dermatologists and, anyway, there is general agreement in the literat-
ure that classifying patients as skin types 1 or 4 is straightforward
(Kricker et al, 1993). Admittedly distinguishing between types 2 and
3 is more problematical. Importantly, in previous studies in patients
with skin cancer we have invariably shown expected associations
between skin type and clinical outcome (Lear et al, 1996). Similarly,
classifying patients as having red hair is straightforward though we
accept that the use of standardized charts will help distinguish different
shades of red.
The second part of the letter from Healy et al refers to our failure
to identify associations between the three alleles studied and suscepti-
bility to melanoma. We are not claiming that the MC1R gene is not
involved in the pathogenesis of melanoma. Indeed, in the discussion
of our paper we stated that ‘‘other allelic variants (possibly some yet
unidentified) may be important’’. Assessing a candidate gene that
demonstrates a relatively large number of alleles is difficult. In our
experience large numbers of cases and controls are needed to firstly,
assess a susceptibility candidate and secondly, determine whether the
gene has any influence on outcome. The influence of most candidate
genes so far described is modest (odds ratios about 2–3). Accordingly,
our aim has been to identify within case groups, subgroups of patients
who are described by particular genotypes and in whom the associ-
ation between genotypes and susceptibility or outcome is much
stronger (Lear et al, 1996). Even with a relatively large study group
(190 controls and 306 melanoma cases), it was difficult to assess
associations between MC1R alleles and host characteristics. Clearly,
larger study groups are needed. These will make sequencing of the
entire gene expensive and, anyway, many allelic variants will be very
rare and/or will have no obvious functional consequence. Assessing
the functional implications of alleles is not always straightforward if
the function of the gene is unclear. Thus, whilst we do not disagree
that sequencing is an important option, screening of selected alleles
in large study groups remains a useful approach. Experiments to assess
function can then be focused on alleles shown to be important in
molecular epidermologic studies.
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